The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Acquired | Acquired



About Psilocin Pharma

Psilocin Pharma Corp. is an arm’s length party incorporated pursuant to the laws of the Province of Ontario.On February 12th, 2020, Psilocin Pharma was acquired by Revive Therapeutics.07 million.

Psilocin Pharma Headquarter Location



Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Psilocin Pharma News

Expert: Psilocybin Is Like Penicillin for the Brain, Rewiring It to Generate New Neurological Pathways

Oct 12, 2021

Michael Frank, CEO of Revive Therapeutics, and Derrick Welsh, COO of Psilocin Pharma, a division of Revive Therapeutics, discuss clinical research investigating novel treatment targets for psilocybin, such as treatment-resistant depression in patients with cancer.

  • What is Psilocin Pharma's latest funding round?

    Psilocin Pharma's latest funding round is Acquired.

  • Who are the investors of Psilocin Pharma?

    Investors of Psilocin Pharma include Revive Therapeutics.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.